Effect of chlorpromazine, mepyramine, prenylamine and reserpine of 5-hydroxytryptamine content and fine structure of rat peritoneal mast cells incubated in vitro.
D000818:Animals; D002021:Buffers; D002118:Calcium / Q000378:metabolism; D002746:Chlorpromazine / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006863:Hydrogen-Ion Concentration; D007474:Ion Exchange; D008274:Magnesium / Q000378:metabolism; D008407:Mast Cells / Q000187:drug effects* / Q000378:metabolism; D008854:Microscopy, Electron; D010537:Peritoneum / Q000166:cytology; D011188:Potassium / Q000378:metabolism; D011299:Prenylamine / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology*; D012701:Serotonin / Q000378:metabolism*; D012964:Sodium / Q000378:metabolism; D013696:Temperature
D002021:Buffers; D006634:Histamine H1 Antagonists; D012701:Serotonin; D012110:Reserpine; D012964:Sodium; D008274:Magnesium; D005947:Glucose; D011299:Prenylamine; D011188:Potassium; D002118:Calcium; D002746:Chlorpromazine